arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Alignment Healthcare, Inc.

ALHC

$14.37 ▲ +1.00 (+7.48%) at close

7 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Alignment Healthcare, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $2.8B

Dividend Yield —

Revenue Growth 46.1% ↘

Op. Margin 0.4% ↗

ROIC 3.0% ↗

FCF / Share $0.57 ↗

Trailing P/E —

Price / Book 16.4x

FCF Yield 4.0%

Debt / Equity 1.80

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$3.95B

↑ +46.1% —

Net Income Profit after all expenses

$-724.00K

↑ +99.4% —

Operating Margin Operating profit as % of sales

0.4%

↑ +109.9% 29th

FCF / Share Free cash flow per share

$0.57

↑ +1740.0% —

Long-Term Debt Long-term obligations

$323.18M

↑ +0.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	46.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+476%)	48.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+503%)	27.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+239%)	22.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+185%)	21.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+172%)	26.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+234%)	—
EPS Growth YoY (%)	100.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	15.2% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	4.8% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	27.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	99.4% Excellent ↑ Excellent Improving Year-over-year change in net income	13.5% Fair ↑ Fair Improving Year-over-year change in net income	1.0% Caution ↑ Caution Improving Year-over-year change in net income	23.4% Good ↑ Good Improving Year-over-year change in net income	-751.8% Weak Weak Year-over-year change in net income	48.7% Excellent Excellent Year-over-year change in net income	—
FCF Growth YoY (%)	N/M	88.9% Excellent Excellent Year-over-year change in free cash flow	-29.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—
Revenue CAGR 3Y (%)	40.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	32.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	23.9% Excellent Excellent Compound annual revenue growth over 3 years	23.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—
Revenue CAGR 5Y (%)	32.7% Excellent Excellent Compound annual revenue growth over 5 years	29.0% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	0.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-98%)	-3.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-125%)	-7.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-147%)	-9.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-160%)	-15.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-202%)	-0.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-104%)	-3.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-126%)
Effective Tax Rate (%) (%)	-2.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	-0.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-100%)	-4.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-139%)	-8.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-168%)	-10.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-187%)	-16.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-239%)	-2.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-120%)	-5.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-149%)
FCF Margin (%) (%)	2.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-0.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-3.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-3.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-6.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	0.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	1.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	-156.28x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.33x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.21x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	3.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-40.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-32.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-3.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	1.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-1.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-0.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-103%)	-128.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-955%)	-94.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-729%)	-62.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-519%)	-63.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-525%)	-74.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-599%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	1.80x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+200%)	3.22x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+437%)	1.03x Caution ↓ Caution Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+72%)	0.68x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+13%)	0.49x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-18%)	4.71x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+685%)	—
Interest Coverage (x)	1.07x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.58x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.02x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-7.03x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-10.21x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.31x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1.98x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$-252.64M	$-111.43M	$-41.09M	$-248.65M	$-315.98M	$-63.14M	$-86.48M
Debt / EBITDA (x)	7.16x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-4.30x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.52x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.44x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.93x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	14.66x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$19.94	$14.17	$9.68	$7.66	—	—	—
Basic EPS, GAAP (USD)	$0.00	$-0.67	$-0.79	$-0.83	$-1.14	—	—
Free Cash Flow per Share (USD)	$0.57	$-0.03	$-0.31	$-0.24	—	—	—
Book Value per Share (USD)	$0.88	$0.52	$0.83	$1.27	$1.63	$0.19	—
Tangible Book Value per Share (USD)	$0.70	$0.32	$0.62	$1.06	$1.48	$0.01	—
Basic Weighted Avg Shares (shares)	198.01M	190.79M	188.42M	187.23M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$394.71M	$309.79M	$220.51M	$314.58M	$385.61M	$111.22M	—
LT Debt (USD)	$323.18M	$321.43M	$161.81M	$160.90M	$150.62M	$144.17M	—
Total Equity (USD)	$179.28M	$99.85M	$156.95M	$238.13M	$306.04M	$30.61M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$3.95B	$2.70B	$1.82B	$1.43B	$1.17B	$959.22M	$756.96M
Depreciation Expense (USD)	$30.40M	$26.87M	$21.41M	$17.27M	$15.81M	$15.10M	$14.92M
Net Income, GAAP (USD)	$-724.00K	$-128.03M	$-148.02M	$-149.55M	$-195.29M	$-22.93M	$-44.73M
Operating Cash Flow (USD)	$139.93M	$34.77M	$-59.19M	$-45.43M	$-78.78M	$7.56M	$9.21M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 27 quarters

Alignment Healthcare, Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ALHC with peers